Sign In
Buy HUGE
$0.0899
+0 (+0%)
At Close: Nov 15, 2024
FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition
09:47am, Tuesday, 21'st Sep 2021
TORONTO--(BUSINESS WIRE)---- $HUGE #RestoreFSD--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a p
Nasdaq-listed FSD Pharma To Advance Psychedelics Pipeline With $9 Million Acquisition Of Lucid Psycheceuticals
05:10pm, Wednesday, 25'th Aug 2021
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE), a life sciences holding company looking at cannabinoid and psychedelic-based medicines, announced it is entering a definitive agreement to acquire Lucid Psych
FSD Pharma To Buy Canadian Psychedelic Pharmaceutical Firm
01:41pm, Wednesday, 25'th Aug 2021
FSD Pharma Inc (NASDAQ: HUGE) shares rebounded after falling in premarket on acquiring a Canada-based psychedelic pharmaceutical company. Related: See Why FSD Pharma Terminated COVID-19 Trial
FSD Pharma to buy pharma group Lucid Psycheceuticals in a stock deal worth US$9 million
09:44am, Wednesday, 25'th Aug 2021
FSD Pharma Inc is to buy Canada-based specialty psychedelic pharma group Lucid Psycheceuticals Inc in a stock deal worth around US$9 million (C$11.3 million). The life sciences holding company said
FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals
09:00am, Wednesday, 25'th Aug 2021
Acquisition Advances Company's Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis Acquisition Advances Company's Strategic Plan Toward a Diversifi
FSD Pharma appoints Anthony Durkacz as its new interim chief executive officer
11:01am, Tuesday, 27'th Jul 2021
FSD Pharma Inc has announced the appointment of Anthony Durkacz as the company's new interim chief executive officer (CEO) as well as the reinstatement of Zeeshan Saeed as FSD Pharma's president. Du
FSD Pharma Inc. Announces Termination of Chief Executive Officer Dr. Raza Bokhari for Cause
08:47am, Tuesday, 27'th Jul 2021
TORONTO--(BUSINESS WIRE)---- $HUGE #RestoreFSD--FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the “Company” or “FSD”) announced today that the board of directors had terminated the empl
Breaking Down a Busy Week of Weed Stocks
12:35pm, Friday, 04'th Jun 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue
FSD Pharma appoints Adnan Bashir as an independent company director
12:10pm, Thursday, 03'rd Jun 2021
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9) announced it has appointed Adnan Bashir as an independent member of the company's board of directors. Bashir, a former general manager of Dubai-based
FSD Pharma says concerned shareholder group-backed nominees elected to board at annual meeting
09:53am, Monday, 17'th May 2021
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9) announced that the slate of board of directors nominees brought forward by a group of concerned shareholders received the necessary votes at the compa
TORONTO--(BUSINESS WIRE)---- $HUGE #ChangeIsHappening--FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the “Company” or “FSD”) is pleased to announce the results of its annual general and
FSD Management and Board Suffers Multiple Court Losses as Shareholder Meeting Approaches
12:49pm, Wednesday, 12'th May 2021
Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - On Monday, May 10, 2021, at the request of Messrs. Anthony Durkacz and Zeeshan Saeed, founding shareholders and members of the group of concerned sh
FSD Pharma files New Animal Drug Application with FDA for FSD201 to treat gastrointestinal enteropathy in dogs
10:21am, Monday, 10'th May 2021
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) said it has submitted to the US Food and Drug Administration an Investigational New Animal Drug Application (IND) for the use of FSD201 to treat gastrointestina
What Happened with Marijuana Stocks This Week?
09:42am, Friday, 07'th May 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) has announced the appointment of Nathan Coyle, the company's corporate controller as its interim chief financial officer with immediate effect, following the d
